Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1996-09-05
1998-08-04
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514535, A61K 31195, A61K 3124
Patent
active
057894442
ABSTRACT:
A method of reducing neurotoxic injury due to acute or chronic neurological insults by administering an anthranilic acid derivative is disclosed.
REFERENCES:
patent: 3138636 (1964-06-01), Scherrer
patent: 3144387 (1964-08-01), Jones
patent: 3313848 (1967-04-01), Scherrer et al.
Hall et al., J. Neurosurg., 64:951-961 (1986).
Buccie et al., Surg. Neurol., 33:12-14 (1990).
Faden et al, Derwent Drug File Abstracts, vol. 92, abstract No. 21000, 1992.
Hall et al, Chemical Abstracts, vol. 105, abstract No. 91569, 1986.
Choi Dennis Wonkyu
Hewett Sandra Jeanne
Jarvis William R. A.
Johnston George W.
Pokras Bruce A.
Tramaloni Dennis P.
Washington University
LandOfFree
Method of reducing glutamate neurotoxicity with anthranilic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of reducing glutamate neurotoxicity with anthranilic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing glutamate neurotoxicity with anthranilic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1177688